Interventions for treating trichomoniasis in women

  • Forna F
  • Gülmezoglu A
Citations of this article
Mendeley users who have this article in their library.
Get full text


BACKGROUND: Around 120 million women worldwide suffer from Trichomonas vaginalis vaginitis every year. The infection is sexually transmitted and is believed to facilitate HIV transmission. OBJECTIVES: To assess the effects of various treatment strategies for trichomoniasis in women. SEARCH STRATEGY: We searched the Cochrane Central Register of Controlled Trials, MEDLINE, and EMBASE. Trials were also identified from reference lists of reviews, through pharmaceutical companies, and by informal discovery. Only published data were used in this review. Date of the most recent search: November, 2002. SELECTION CRITERIA: Randomised or quasi-randomised trials of different treatment strategies in women with trichomoniasis. Different antitrichomonal drugs or doses were eligible, as were comparisons of treatment with no treatment or placebo. DATA COLLECTION AND ANALYSIS: Trial quality was assessed and data extracted by two reviewers independently using standard criteria. MAIN RESULTS: Fifty-four trials were included. Nitroimidazole drugs seem to be effective in achieving parasitological cure in short term follow up. Partner treatment can be effective in decreasing longer term reinfection rates. REVIEWER'S CONCLUSIONS: Parasitological cure can be achieved by single oral dose of nitroimidazole. Further research should focus on developing effective partner treatment strategies to prevent reinfections and reduce trichomoniasis prevalence.




Forna, F., & Gülmezoglu, A. M. (2003). Interventions for treating trichomoniasis in women. Cochrane Database of Systematic Reviews.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free